International ophthalmology clinicsHumansMyelin-Oligodendrocyte GlycoproteinAutoantibodiesOptic NeuritisDisease Management
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Mechanisms, Syndromes, and Management.
Rachel F Dolan, Nitin Rangu, Deanna H Dang, Andrew T Melson
Published: 202610.1097/IIO.0000000000000597
Abstract
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) has emerged as a distinct demyelinating condition with unique clinical and radiographic characteristics that differentiate it from multiple sclerosis (MS) and aquaporin-4 antibod…
Preview only. Read the full abstract at the source